Back to results
US 2022/0033430 A1Published application
Orally active prodrug of gemcitabine
AssigneeTNT Medical Corporation
InventorsXiang Li, Bing Ying Li, Starr Sing Chung Cheng, Andrew Wang
Life of this patent
Estimating the term…
Abstract
The disclosure includes compounds of Formula (I): wherein R1, R2, and R3, are defined herein. Also disclosed is a method for treating a neoplastic disease with these compounds.
Claims4
A compound of Formula (I), or an N-oxide thereof, or a pharmaceutically acceptable salt, solvate, polymorph, tautomer, stereoisomer, an isotopic form, or a prodrug of said compound of Formula (I) or N-oxide thereof:
- wherein
- R1 is
- in which m is an integer from 1 to 20;
- and
- each of R2, and R3, independently, is
2 more elements
Dependencies are inferred from the claim text.